Mesalamine Information
What's inside Mesalamine
Mesalamine Active Ingredients: mesalamine, details.| Mesalamine Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Mesalamine - | powder | compounding | 100.0 gram(s) | OTC |
| Mesalamine 4 g/60 mL | enema | rectal | 60.0 milliliter(s) | OTC |
Recent Mesalamine Side Effects
Posted by siobhan over 4 years ago
My side effects include....titeness in my chest, shortness of breath, I am breaking out all over my face.... and sleeoy all t...
Mesalamine in the News
Shire Launches Patient Education Forums on Better Managing the ... - PharmaLive.com (press release)
Shire Pharmaceuticals is a specialty biopharmaceutical company that markets once-daily LIALDA(TM) (mesalamine) for the induction of remission in patients ...
Mon Mar 10 08:42:40 -0400 2008
IST Targets: Introduces Shire plc to our Bluechips Portfolio - Trading Markets (press release)
MEZAVANT is the first and only Health Canada approved once-daily oral formulation of mesalamine, and the first mesalamine to be approved by Health Canada ...
Thu Jan 31 11:41:38 -0500 2008
Shire plc: Excellent Performance Across All Areas of the Business ... - PR Newswire (press release)
LIALDA, the only once-daily oral formulation of mesalamine was approved by the FDA in January 2007 and launched in the US in March 2007, acquiring 8.0% ...
Thu Feb 21 09:44:20 -0500 2008
Mesalamine Chemical Information
mesalamine - An agent derived from sulfasalazine, an antiinflammatory agent. Mesalamine may reduce inflammation through inhibition of cyclooxygenase and prostaglandin production. Following rectal or oral administration, only a small amount of mesalamine is absorbed; the remainder, acting topically, reduces bowel inflammation, diarrhea, rectal bleeding and stomach pain. (NCI04)
Mesalamine RSS Feed
